Maggie A. Smith, DNP, MSN/Ed, RN, OCN is Field Medical Director in GU Oncology at Pfizer, and Director-at-Large for the national Oncology Nursing Society (ONS), as well as Nominating-Chair and ...

Patricia McCrink, MSN, RN, CRT, of Miami Cancer Institute, completed treatment for stage IV non-Hodgkin lymphoma and returned to nursing with a deeper capacity for compassion and patient advocacy.

FDA approval covers PIK3CA–wild-type HR+/HER2− advanced breast cancer progressing after ≥1 metastatic endocrine line, positioning gedatolisib as a post-endocrine targeted option with fulvestrant ± ...

Patricia McCrink’s 30+ years in oncology nursing are distinguished by sustained bedside presence, emotional support, and ...

Before starting cell therapy, patients need more than hope — they need a plan. Dr. Muhammad Tariq breaks down what to expect ...

There is a particular kind of fear that settles in after a lung cancer diagnosis — not just fear of the disease, but fear of ...

Traditional approval establishes confirmed clinical benefit for selpercatinib in tumor-agnostic RET fusion–positive solid tumors after progression or when no satisfactory options exist. LIBRETTO-001 ...

Focal cryotherapy is changing prostate cancer care. Dr. Herbert Lepor explains this milestone treatment and what it means for patients.

Early Type 1 diabetes experience created durable empathy for loss of control, anticipatory anxiety and treatment fatigue, ...

GLP-1 receptor agonists promote weight loss via gut-hormone mimetics that curb appetite, slow gastric emptying, and improve ...

Chermaine Wulff of Valley Medical Center goes beyond clinical duties to champion her patients' final wishes, advocate for nursing staff and strengthen oncology nursing across the Pacific Northwest.